Marketwatch Sun Pharma Q2 takeaways: Debt comes down, R&D spends increase & more Admin November 3, 2020 Analysts believe the performance will give a boost to shares of the company that have seen undeserving selling. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
